Volkmann ER, Andréasson K, Smith V (2023) Systemic sclerosis. Lancet 401(10373):304–318
Nihtyanova SI (2010) Denton CP (2010) Autoantibodies as predictive tools in systemic sclerosis. Nat Rev Rheumatol 6:112–116
Article CAS PubMed Google Scholar
Sakkas LI, Chikanza IC, Platsoucas CD (2006) Mechanisms of disease: the role of immune cells in the pathogenesis of systemic sclerosis. Nat Clin Pract Rheumatol 2:679–685
Article CAS PubMed Google Scholar
Skaug B, Khanna D, Swindell WR, Hinchcliff ME, Frech TC, Steen VD et al (2020) Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile. Ann Rheum Dis 79:379–386. https://doi.org/10.1136/annrheumdis-2019-215894
Article CAS PubMed Google Scholar
Li X, Sundquist J, Sundquist K (2009) Risks of rheumatic diseases in first-and second-generation immigrants in Sweden: a nationwide follow up study. Arthritis Rheum 60:1588–1596
Marie I, Gehanno JF (2015) Environmental risk factors of systemic sclerosis. Semin Immunopathol 37:463–473. https://doi.org/10.1007/s00281-015-0507-3
Article CAS PubMed Google Scholar
Rosa JE, Soriano E, Narvaez-Ponce L, del Cid CC, Imamura PM, Catoggio LJ (2011) Incidence and prevalence of systemic sclerosis in a healthcare plan in Buenos Aires. J Clin Rheumatol 17:59–63. https://doi.org/10.1097/RHU.0b013e31820e7e8d
Jiwrajka N, Anguera MC (2022) The X in seX-biased immunity and autoimmune rheumatic disease. J Exp Med 219:e20211487. https://doi.org/10.1084/jem.20211487
Article CAS PubMed PubMed Central Google Scholar
Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, Liu S, Yang JK (2020) Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health 8:152. https://doi.org/10.3389/fpubh.2020.00152
Article PubMed PubMed Central Google Scholar
Isnardi CA, Roberts K, Saurit V, Petkovic I, Baez RM, Quintana R et al (2023) Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry. Clin Rheumatol 42:563–578. https://doi.org/10.1007/s10067-022-06393-8
Di Maso M, Delbue S, Sampietro M, Ferraroni M, Modenese A, Dolci M et al (2024) Assessing the association between biomarkers and COVID-19 mortality using the joint modelling approach. Life (Basel) 14:343. https://doi.org/10.3390/life14030343
Article CAS PubMed Google Scholar
Hasseli R, Hanses F, Stecher C, Weise T et al (2024) The protective effect of tumor necrosis factor-alpha inhibitors in COVID-19 in patients with inflammatory rheumatic diseases compared to the general population-a comparison of two German registries. Front Med (Lausanne) 11:1332716. https://doi.org/10.3389/fmed.2024.1332716
Yazdany J, Ware A, Wallace ZS, Bhana S, Grainger R, Hachulla E et al (2024) Impact of risk factors on COVID-19 outcomes in unvaccinated people with rheumatic diseases: a comparative analysis of pandemic epochs using the COVID-19 global rheumatology alliance registry. Arthritis Care Res (Hoboken) 76:274–287. https://doi.org/10.1002/acr.25220
Article CAS PubMed Google Scholar
Sakkas LI, Chikanza IC (2024) Sex bias in immune response: it is time to include the sex variable in studies of autoimmune rheumatic diseases. Rheumatol Int 44:203–209
Ohta A, Nagai M, Nishina M, Tomimitsu H, Kohsaka H (2013) Age at onset and gender distribution of systemic lupus erytematosus, polymyositis/dermatomyositis, and systemic sclerosis in Japan. Mod Rheumatol 23:759–764
Marie I, Menard JF, Duval-Modeste AB, Joly P, Domonique S et al (2015) Association of occupational exposure with features of systemic sclerosis. J Am Acad Dermatol 72:456–464. https://doi.org/10.1016/j.jaad.2014.11.027
Patel S, Morrisroe K, Proudman S, Hansen D, Sahhar J, Sim MR et al (2020) Occupational silica exposure in an Australian systemic sclerosis cohort. Rheumatology (Oxford) 59:3900–3905. https://doi.org/10.1093/rheumatology/keaa446
Article CAS PubMed Google Scholar
Boudigaard SH, Schlunssen V, Vestergaard M, Sondergaard K, Torren K, Peters S et al (2021) Occupational exposure to respirable crystalline silica and risk of autoimmune rheumatic diseases: a nationwide cohort study. Int J Epidemiol 50:1213–1226. https://doi.org/10.1093/ije/dyaa287
Article PubMed PubMed Central Google Scholar
Thoreau B, Eustache M, Fievet A, Lasfargues G, Plantier L, Diot E (2022) Independent association between occupational exposure and decline of FVC in systemic sclerosis: a multicenter recruitment retrospective cohort study. Chest 161:1011–1021. https://doi.org/10.1016/j.chest.2021.11.009
Article CAS PubMed Google Scholar
Elhai M, Avouac J, Walker UA, Matucci-Cerinic M, Riemekasten G, Airo P et al (2016) A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study. Ann Rheum Dis 75:163–169. https://doi.org/10.1136/annrheumdis-2014-206386
Wirz EG, Jaeger VK, Allanore Y, Riemekasten G, Hachulla E et al (2016) Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database. Ann Rheum Dis 75:1285–1292. https://doi.org/10.1136/annrheumdis-2015-207271
Carreira PE, Carmona L, Joven BE, Loza E, Andreu JL, Riemekasten G et al (2018) Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database. Clin Exp Rheumatol 36(Suppl 113):68–75
Al-Dhaher F, Pope JE, Quimet JM (2010) Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin Arthritis Rheum 39:269–277
Hou YY et al (2022) Sex disparities in clinical characteristics of Chinese patients with systemic sclerosis. Zhonghua Nei Ke Za Zhi 61:403–408
Peoples C, Medsger TA Jr, Lucas M, Rosario BL, Feghali-Bostwick CA (2016) Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes. J Scleroderma Relat Disord 1:177–240
Kassamali B, Kus KJB, Mazori DR, Maher J, Lopez CG, Kassamali AA et al (2022) Race and gender differences in systemic sclerosis: a retrospective multicenter cohort. Int J Dermatol 61:e437–e438. https://doi.org/10.1111/ijd.15908
De Angelis R, Giuggioli D, Bajocchi G, Dagna L, Zanframundo G, Foti R et al (2022) Sex-related differences in systemic sclerosis: a multicenter cross-sectional study from the National Registry of the Italian Society for Rheumatology. J Rheumatol 49:176–185. https://doi.org/10.3899/jrheum.210794
Freitas R, Martins P, Dourado E, Santiago T, Guimaraes F, Fernandes BM et al (2022) Gender differences in clinical features and outcomes of a Portuguese systemic sclerosis cohort. Clin Rheumatol 41:1139–1144. https://doi.org/10.1007/s10067-021-05997-w
Wangkaew S, Tungteerabunditkul S, Prasertwittayakij N, Euathrongchit J (2020) Comparison of clinical presentation and incidence of cardiopulmonary complications between male and female Thai patients with early systemic sclerosis: inception cohort study. J Clin Rheumatol 39:103–112
Nguyen C, Berezne A, Baubet T, Mestre-Stanislas C, Rannou F, Papelard A et al (2011) Association of gender with clinical expression, quality of life, disability, and depression and anxiety in patients with systemic sclerosis. PLoS ONE 6:e17551. https://doi.org/10.1371/journal.pone.0017551
Article CAS PubMed PubMed Central Google Scholar
Xu D, Li MT, Hou Y, Wang Q, Hu CJ, Song N et al (2013) Clinical characteristics of systemic sclerosis patients with digital ulcers in China. Clin Exp Rheumatol 31(2 Suppl 76):46–49
Comments (0)